NM
Nitinkumar Makvana
About Nitinkumar Makvana
Data last updated:
Nitinkumar Makvana is a Director at Sycon Clinical Research Private Limited (since 2021). The company operates in Pharma. Sycon Clinical Research Private Limited reported revenue of ₹4.10 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 26 Jul 2021 | 2021 | ₹4.10 Cr (FY 2025) | Active |
Board colleagues of Nitinkumar Makvana
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bhavikkumar Ramanlal Patel | 09254157 | Sycon Clinical Research Private Limited | Director |
| Kamlesh Manilal Panchal | 10937647 | Sycon Clinical Research Private Limited | Director |
| Umang Chandulal Gandhi | 09291056 | Sycon Clinical Research Private Limited | Director |
| Viralkumar Kirtikumar Patel | 09290872 | Sycon Clinical Research Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nitinkumar Makvana
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nitinkumar Makvana
Nitinkumar Makvana currently holds 1 directorship: Sycon Clinical Research Private Limited (Director, since 26 Jul 2021, revenue ₹4.10 Cr (FY 2025)).
Nitinkumar Makvana was first appointed on 26 Jul 2021 as Director at Sycon Clinical Research Private Limited.
The current boards of Nitinkumar Makvana's companies include Bhavikkumar Ramanlal Patel (Sycon Clinical Research Private Limited), Kamlesh Manilal Panchal (Sycon Clinical Research Private Limited), Umang Chandulal Gandhi (Sycon Clinical Research Private Limited), Viralkumar Kirtikumar Patel (Sycon Clinical Research Private Limited).